Navigation Links
Minister from MP Urges to Ban the Sale of Sex Toys

Saying that the sale of sex toys in India would have "severe consequences in society", a Madhya Pradesh minister has urged Prime Minister Manmohan Singh to convene an all-party meeting to discuss the issue.

Even as a condom with a vibrating ring continues to stir controversy in the state, Public Works Department (PWD) Minister Kailash Vijayvargiya urged in a letter to Manmohan Singh that the import and sale of products like sex toys be banned.

"The Madhya Pradesh government stresses yoga shiksha (yoga education) instead of the centre's yon shiksha (sex education). There is an urgent need to rise above party lines in this matter," Vijayvargiya said.

About six months ago, HLL started to sell Crezendo - a three-condom pack with a vibrating ring - at a price of Rs.125. The Madhya Pradesh government is contemplating a ban on its sale in the state if Crezendo is proved to be a sex toy.

"Hindustan Latex Ltd (HLL), which is under the union Health and Family Welfare Ministry, recently launched the vibrating ring that is imported from China," Vijayvargiya said.

He quoted statistics to say that sex toys had an international market in the range of Rs.400 billion and China manufactured 70 percent of such toys. "It has found a new market in India, now officially since HLL is purchasing the product from it.

"The sale of such toys will lead to severe consequences in society. And they should be banned. But the union government is turning a Nelson's eye despite such sale taking place openly in the national capital," according to Vijayvargiya.

While Vijayvargiya is convinced that Crezendo is a sex toy, Mukesh Gupta, an HLL distributor here, denies the allegation. "It is not a sex toy but simply a pleasure enhancer that is in great demand," Gupta said.

But the minister said: "Condoms are used for family planning. When they are used for pleasure with devices like vibrators
'"/>




Page: 1 2

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Prime Minister Manmohan Against Incentive-Based Population Control
3. Prime Minister Declares War on AIDS
4. Medical Curriculum in India to change says Health Minister
5. Health Minister fires another salvo at MCI
6. Indian Prime Minister undergoes Minor Surgery in AIIMS
7. Indian Health Minister interested to import bird flu vaccine
8. Bulgaria Agriculture Minister ban import of poultry from Macedonia and Croatia
9. India Has No Case Of Avian Flu Says Health Minister
10. Indian Minister wanted Media to Propaganda HIV/AIDS awareness
11. Minister Defends Hike in AIIMS Treatment Charges
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Minister from Urges Ban the Sale Sex Toys

Breaking Medicine News(10 mins):Health News:InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software 2Health News:InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software 3Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 2Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 3Health News:REES Announces New Baltimore Office 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 4Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 5Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 6Health News:Buffalo Personal Injury Lawyers Cellino & Barnes Donate $1M to UB School of Law, Appear on Cover of School's Philanthropy Magazine 2
Other Medicine News:Health News:Texas Cancer Organizations Urge State Legislature to Fully Fund the Cancer Prevention and Research Institute of Texas 2Health News:Gen-Probe Reports Financial Results for First Quarter 2009 2Health News:Gen-Probe Reports Financial Results for First Quarter 2009 3Health News:Gen-Probe Reports Financial Results for First Quarter 2009 4Health News:Gen-Probe Reports Financial Results for First Quarter 2009 5Health News:Gen-Probe Reports Financial Results for First Quarter 2009 6Health News:Gen-Probe Reports Financial Results for First Quarter 2009 7Health News:Gen-Probe Reports Financial Results for First Quarter 2009 8Health News:Gen-Probe Reports Financial Results for First Quarter 2009 9Health News:Gen-Probe Reports Financial Results for First Quarter 2009 10Health News:Gen-Probe Reports Financial Results for First Quarter 2009 11Health News:Gen-Probe Reports Financial Results for First Quarter 2009 12Health News:Gen-Probe Reports Financial Results for First Quarter 2009 13Health News:Gen-Probe Reports Financial Results for First Quarter 2009 14Health News:Gen-Probe Reports Financial Results for First Quarter 2009 15Health News:Gen-Probe Reports Financial Results for First Quarter 2009 16Health News:Gen-Probe Reports Financial Results for First Quarter 2009 17Health News:Gen-Probe Reports Financial Results for First Quarter 2009 18Health News:Woodward Labs Reports Sales Spike for HandClens(R) Alcohol-Free Hand Sanitizer During Swine Flu Epidemic 2Health News:Woodward Labs Reports Sales Spike for HandClens(R) Alcohol-Free Hand Sanitizer During Swine Flu Epidemic 3Health News:Chlamydia may play role in a type of arthritis 2
Other Medicine Technology:Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 2Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 3Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 4Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 5Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 6Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 7Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 8Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 9Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 2Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 3Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 4Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 5